Earnings Feed
Start Free
|4May 28, 6:59 PM ET

PHARMACYCLICS INC 4

4 · PHARMACYCLICS INC · Filed May 28, 2015

Insider Transaction Report

Form 4
Period: 2015-05-26
PHARMACYCLICS INCPCYC
Mehta Minesh
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−238→ 0 total
    Exercise: $108.44Exp: 2024-01-02→ Common Stock (238 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $14.26Exp: 2021-12-15→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−157→ 0 total
    Exercise: $107.42Exp: 2024-04-01→ Common Stock (157 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−184→ 0 total
    Exercise: $139.89Exp: 2023-10-01→ Common Stock (184 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−407→ 0 total
    Exercise: $89.58Exp: 2024-07-01→ Common Stock (407 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $49.00Exp: 2022-11-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−146→ 0 total
    Exercise: $257.01Exp: 2025-04-07→ Common Stock (146 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−4,000→ 0 total
    Exercise: $2.30Exp: 2018-09-10→ Common Stock (4,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−208→ 0 total
    Exercise: $59.28Exp: 2022-07-02→ Common Stock (208 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−314→ 0 total
    Exercise: $115.80Exp: 2024-10-01→ Common Stock (314 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−222→ 0 total
    Exercise: $124.46Exp: 2025-01-02→ Common Stock (222 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−683→ 0 total
    Exercise: $28.47Exp: 2022-04-02→ Common Stock (683 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−267→ 0 total
    Exercise: $65.56Exp: 2022-10-01→ Common Stock (267 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−322→ 0 total
    Exercise: $61.44Exp: 2023-01-02→ Common Stock (322 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−325→ 0 total
    Exercise: $79.67Exp: 2023-04-01→ Common Stock (325 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−304→ 0 total
    Exercise: $85.39Exp: 2023-07-01→ Common Stock (304 underlying)
Footnotes (1)
  • [F1]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION